BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 25504931)

  • 1. Sialic acid-binding immunoglobulin-type lectin H-positive plasmacytoid dendritic cells drive spontaneous lupus-like disease development in B6.Nba2 mice.
    Davison LM; Jørgensen TN
    Arthritis Rheumatol; 2015 Apr; 67(4):1012-22. PubMed ID: 25504931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting mechanisms of interferon-α inhibition by intravenous immunoglobulin after induction by immune complexes versus Toll-like receptor agonists.
    Wiedeman AE; Santer DM; Yan W; Miescher S; Käsermann F; Elkon KB
    Arthritis Rheum; 2013 Oct; 65(10):2713-23. PubMed ID: 23840006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited Effect of Indolamine 2,3-Dioxygenase Expression and Enzymatic Activity on Lupus-Like Disease in B6.Nba2 Mice.
    Davison LM; Liu JC; Huang L; Carroll TM; Mellor AL; Jørgensen TN
    Front Immunol; 2019; 10():2017. PubMed ID: 31555267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2 antagonists kill plasmacytoid dendritic cells from lupus-prone mice and dampen interferon-α production.
    Zhan Y; Carrington EM; Ko HJ; Vikstrom IB; Oon S; Zhang JG; Vremec D; Brady JL; Bouillet P; Wu L; Huang DC; Wicks IP; Morand EF; Strasser A; Lew AM
    Arthritis Rheumatol; 2015 Mar; 67(3):797-808. PubMed ID: 25418983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and functional alterations of pDCs in lupus-prone mice.
    Zhou Z; Ma J; Xiao C; Han X; Qiu R; Wang Y; Zhou Y; Wu L; Huang X; Shen N
    Sci Rep; 2016 Feb; 6():20373. PubMed ID: 26879679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
    Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
    Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I interferon signaling is involved in the spontaneous development of lupus-like disease in B6.Nba2 and (B6.Nba2 x NZW)F(1) mice.
    Jørgensen TN; Roper E; Thurman JM; Marrack P; Kotzin BL
    Genes Immun; 2007 Dec; 8(8):653-62. PubMed ID: 17882225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-α accelerates murine systemic lupus erythematosus in a T cell-dependent manner.
    Liu Z; Bethunaickan R; Huang W; Lodhi U; Solano I; Madaio MP; Davidson A
    Arthritis Rheum; 2011 Jan; 63(1):219-29. PubMed ID: 20954185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.
    Blomberg S; Eloranta ML; Magnusson M; Alm GV; Rönnblom L
    Arthritis Rheum; 2003 Sep; 48(9):2524-32. PubMed ID: 13130472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice.
    Jørgensen TN; Thurman J; Izui S; Falta MT; Metzger TE; Flannery SA; Kappler J; Marrack P; Kotzin BL
    Genes Immun; 2006 Oct; 7(7):555-67. PubMed ID: 16900204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgE Inhibits Toll-like Receptor 7- and Toll-like Receptor 9-Mediated Expression of Interferon-α by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
    Khoryati L; Augusto JF; Shipley E; Contin-Bordes C; Douchet I; Mitrovic S; Truchetet ME; Lazaro E; Duffau P; Couzi L; Jacquemin C; Barnetche T; Vacher P; Schaeverbeke T; Blanco P; Richez C;
    Arthritis Rheumatol; 2016 Sep; 68(9):2221-31. PubMed ID: 26991804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation of SigH+ pDCs in B6.Nba2 mice prevents lupus-like disease development only if started before disease is fully established.
    Campbell NO; Davison LM; Banerjee S; Nguyen JK; Krafcik S; Silverman RH; Jorgensen TN
    Lupus; 2022 Nov; 31(13):1619-1629. PubMed ID: 36134524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous CD4+ T Cell Activation and Differentiation in Lupus-Prone B6.Nba2 Mice Is IFNAR-Independent.
    Keller EJ; Dvorina N; Jørgensen TN
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B lymphocytes enhance interferon-α production by plasmacytoid dendritic cells.
    Berggren O; Hagberg N; Weber G; Alm GV; Rönnblom L; Eloranta ML
    Arthritis Rheum; 2012 Oct; 64(10):3409-19. PubMed ID: 22736048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production.
    Zhang X; Lindwall E; Gauthier C; Lyman J; Spencer N; Alarakhia A; Fraser A; Ing S; Chen M; Webb-Detiege T; Zakem J; Davis W; Choi YS; Quinet R
    Lupus; 2015 Aug; 24(9):909-17. PubMed ID: 25654980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dichotomous effects of complete versus partial class II major histocompatibility complex deficiency on circulating autoantibody levels in autoimmune-prone mice.
    Stohl W; Xu D; Metzger TE; Kim KS; Morel L; Kotzin BL
    Arthritis Rheum; 2004 Jul; 50(7):2227-39. PubMed ID: 15248222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-interferon alpha treatment in SLE.
    Kirou KA; Gkrouzman E
    Clin Immunol; 2013 Sep; 148(3):303-12. PubMed ID: 23566912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
    Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ
    Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.